Journey Medical Corp

DERMSEC EDGAR

Pharmaceutical Preparations(DE)CIK: 1867066

Concept	FY2024	FY2023	FY2022	FY2021
Revenue from Contract with Customer, Excluding Assessed Tax	$59.7M	$71.0M	$63.1M	$44.5M
Cost of Revenue	$22.9M	$30.8M	$32.1M	$14.6M
Research and Development Expense	$7.5M	$10.9M	$2.7M	$2.7M
Selling, General and Administrative Expense	$43.9M	$59.5M	$39.8M	$22.1M
Operating Income (Loss)	-$2.1M	-$27.5M	-$34.9M	$7.9M
Interest Expense	—	$2.0M	$7.0M	$698.0K
Nonoperating Income (Expense)	-$1.6M	-$2.0M	-$7.5M	-$698.0K
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest	-$3.6M	-$29.6M	-$42.4M	$7.2M

Concept	FY2024	FY2023	FY2022	FY2021
Assets	$76.8M	$105.2M	$97.3M	$51.9M
Assets, Current	$56.5M	$77.7M	$84.5M	$35.2M
Cash and Cash Equivalents, at Carrying Value	$27.4M	$32.0M	$49.1M	$8.2M
Accounts Receivable, after Allowance for Credit Loss, Current	$15.2M	$28.2M	$23.1M	$23.9M
Inventory, Net	$10.2M	$14.2M	$9.9M	$1.4M
Liabilities	$56.5M	$88.2M	$55.2M	$41.6M
Liabilities, Current	$41.9M	$66.8M	$51.6M	$28.1M
Long-term Debt	$14.6M	$27.8M	$27.8M	—
Accounts Payable, Current

Concept	FY2024	FY2023	FY2022	FY2021
Net Cash Provided by (Used in) Operating Activities	$5.2M	-$13.5M	-$2.2M	$5.1M
Net Cash Provided by (Used in) Investing Activities	-$5.0M	-$20.0M	-$10.0M	-$1.2M
Net Cash Provided by (Used in) Financing Activities	-$4.8M	$16.5M	$53.0M	-$487.0K

Access SEC EDGAR data via REST API. Free tier available.

from sec_edgar import SecEdgar

api = SecEdgar("YOUR_KEY")
api.revenue("AAPL", limit=5)